Floatz logo

P-METHOXYACETANILIDE

Fatty Liver

Virginia Commonwealth UniversitySmall moleculePhase 3Dormant
B
58/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
47/ 100
Competitive Position
81/ 100

Competitive context

27 Active assets in the Fatty Liver cohort.

Asset / SponsorPhaseRating
Metformin
Leiden University Medical Center
Phase 4BBB
Alpha Tocopherol
Yuen Kah Hay
Phase 4BB
Rilpivirine
Fundacion SEIMC-GESIDA
Phase 4BB
Empagliflozin
Seoul National University Bundang Hospital
Phase 4BB
Raltegravir
Helsinki University Central Hospital
Phase 4BB

View all 50 →

Same molecule, other indications

P-METHOXYACETANILIDE is also rated in:

cirrhosis of liverDormant
B
Indicative ·
56 / 100
View asset →
Hepatitis CDormant
CCC
Indicative ·
53 / 100
View asset →
NASH - Nonalcoholic SteatohepatitisDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →